Literature DB >> 3174152

Post-herpetic neuralgia: post-mortem analysis of a case.

C P N Watson1, C Morshead, D Van der Kooy, J Deck, R J Evans.   

Abstract

The morphological and biochemical substrates of the severe pain in post-herpetic neuralgia (PHN) are unclear. This report is an autopsy study of a 67-year-old male with severe PHN during the last 5 years of his life over the right T7-8 dermatomes. The dorsal horn of the thoracic spinal cord of the affected side was atrophic from T4 to T8, with loss of both myelin and axons. Despite this, only the T8 ganglion was affected by fibrosis and cell loss and only the nerve roots at that level appeared affected. Markers of unmyelinated afferents (substance P), substantia gelatinosa neurons (opiate receptors), glial cells (glial fibrillary acidic protein), and descending spinal projections (dopamine-beta-hydroxylase and serotonin) were not different at affected versus non-affected spinal cord levels. The pain of PHN may result from the uninhibited activity of unmyelinated primary afferents as a result of the loss of myelinated afferent fibers and the possible presence of hypersensitive neurons in the dorsal horn.

Entities:  

Mesh:

Year:  1988        PMID: 3174152     DOI: 10.1016/0304-3959(88)90158-3

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  21 in total

Review 1.  Herpes zoster and postherpetic neuralgia: past, present and future.

Authors:  Gary J Bennett; C Peter N Watson
Journal:  Pain Res Manag       Date:  2009 Jul-Aug       Impact factor: 3.037

Review 2.  Problems in the differential diagnosis of chronic pain.

Authors:  K L Casey
Journal:  Anesth Prog       Date:  1990 Mar-Jun

Review 3.  The role of sensory fiber demography in trigeminal and postherpetic neuralgias.

Authors:  A F DaSilva; M F DosSantos
Journal:  J Dent Res       Date:  2011-06-13       Impact factor: 6.116

4.  The cost of treatment for post-herpetic neuralgia in the UK.

Authors:  L Davies; L Cossins; D Bowsher; M Drummond
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

5.  Somatosensory findings in postherpetic neuralgia.

Authors:  T Nurmikko; D Bowsher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-02       Impact factor: 10.154

Review 6.  Herpes zoster management.

Authors:  J A Katz; J C Phero; J S McDonald; D B Green
Journal:  Anesth Prog       Date:  1989 Mar-Apr

7.  Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy.

Authors:  P Y Geha; M N Baliki; D R Chialvo; R N Harden; J A Paice; A V Apkarian
Journal:  Pain       Date:  2006-10-25       Impact factor: 6.961

8.  Clinical Usage of the Adjuvanted Herpes Zoster Subunit Vaccine (HZ/su): Revaccination of Recipients of Live Attenuated Zoster Vaccine and Coadministration With a Seasonal Influenza Vaccine.

Authors:  Michael N Oxman; Ruth Harbecke; David M Koelle
Journal:  J Infect Dis       Date:  2017-12-12       Impact factor: 5.226

Review 9.  A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain.

Authors:  C Peter N Watson; Ian Gilron; Jana Sawynok
Journal:  Pain Res Manag       Date:  2010 May-Jun       Impact factor: 3.037

10.  Characterization of the host immune response in human Ganglia after herpes zoster.

Authors:  Kavitha Gowrishankar; Megan Steain; Anthony L Cunningham; Michael Rodriguez; Peter Blumbergs; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.